TITLE
Early Changes In B Cell Subsets Predict Risk Of Autoimmunity Following Combination Immune Checkpoint Blockade

ORGANISM
Homo sapiens

SUMMARY
We report changes in B cells in patients treated with combination immune checkpoint blockade (CCB; anti-CTLA4 and anti-PD1)

DESIGN
We examine CD19+ sorted B cells before and after CCB therapy

PLATFORM
GPL16791 Illumina HiSeq 2500 (Homo sapiens)

CITATIONS
Has this study been published? Please login to update or notify GEO .

